Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume 9, Issue 5, Pages 629-650
Publisher
Informa UK Limited
Online
2014-10-20
DOI
10.1586/17474124.2015.965143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial
- (2014) Yumie Takeshita et al. DIABETOLOGIA
- Glucose-Induced Glucagon-Like Peptide 1 Secretion Is Deficient in Patients with Non-Alcoholic Fatty Liver Disease
- (2014) Christine Bernsmeier et al. PLoS One
- Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
- (2014) Stefano Ballestri WORLD JOURNAL OF GASTROENTEROLOGY
- Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
- (2014) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets
- (2013) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease
- (2013) Susan S Cho et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Integration of signals generated by nutrients, hormones, and exercise in skeletal muscle
- (2013) Scot R Kimball AMERICAN JOURNAL OF CLINICAL NUTRITION
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease
- (2013) E. Scorletti et al. Annual Review of Nutrition
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
- (2013) Ebenezer T. Oni et al. ATHEROSCLEROSIS
- Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology
- (2013) P. Loria et al. ATHEROSCLEROSIS
- The cardiovascular safety of incretin-based therapies: a review of the evidence
- (2013) John R Petrie Cardiovascular Diabetology
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
- (2013) David C. Goff et al. CIRCULATION
- Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
- (2013) H. Kahal et al. CLINICAL ENDOCRINOLOGY
- Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease
- (2013) Meropi D. Kontogianni et al. CLINICAL NUTRITION
- The Role of Medications for the Management of Patients with NAFLD
- (2013) Natalia Mazzella et al. Clinics in Liver Disease
- Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis
- (2013) Hye Duck Choi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Is mipomersen ready for clinical implementation? A transatlantic dilemma
- (2013) Barbara Sjouke et al. CURRENT OPINION IN LIPIDOLOGY
- Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
- (2013) Amedeo Lonardo et al. CURRENT PHARMACEUTICAL DESIGN
- Statin use and risk of hepatocellular carcinoma
- (2013) Shih-Wei Lai et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial)
- (2013) Elisabetta Bacchi et al. HEPATOLOGY
- Dietary fructose in nonalcoholic fatty liver disease
- (2013) Miriam B. Vos et al. HEPATOLOGY
- Effects of Liraglutide, a Human Glucagon-like Peptide-1 Analogue, on Body Weight, Body Fat Area and Body Fat-related Markers in Patients with Type 2 Diabetes Mellitus
- (2013) Daisuke Suzuki et al. INTERNAL MEDICINE
- Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
- (2013) Matti J. Tikkanen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
- (2013) Barbara Fruci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antioxidant Supplements to Prevent Mortality
- (2013) Goran Bjelakovic et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Improved Hepatic Lipid Composition Following Short-Term Exercise in Nonalcoholic Fatty Liver Disease
- (2013) Jacob M. Haus et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
- (2013) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- Diet and exercise in management of obesity and overweight
- (2013) Kwong Ming Fock et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
- (2013) Marno C. Ryan et al. JOURNAL OF HEPATOLOGY
- Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients
- (2013) Salvatore Petta et al. JOURNAL OF HEPATOLOGY
- Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
- (2013) Derrick M. Van Rooyen et al. JOURNAL OF HEPATOLOGY
- From NAFLD in clinical practice to answers from guidelines
- (2013) Fabio Nascimbeni et al. JOURNAL OF HEPATOLOGY
- Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial
- (2013) J. de Jager et al. JOURNAL OF INTERNAL MEDICINE
- Effects of Sitagliptin on Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Rats
- (2013) Selvihan Beysel Akaslan et al. Metabolic Syndrome and Related Disorders
- Nonalcoholic Fatty Liver Disease and Reduced Serum Vitamin D3 Levels
- (2013) Giovanni Targher et al. Metabolic Syndrome and Related Disorders
- Irisin in patients with nonalcoholic fatty liver disease
- (2013) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
- (2013) Shin Yoshimoto et al. NATURE
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Pharmacological agents for NASH
- (2013) Vlad Ratziu Nature Reviews Gastroenterology & Hepatology
- Chemopreventive strategies in hepatocellular carcinoma
- (2013) Siddharth Singh et al. Nature Reviews Gastroenterology & Hepatology
- The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience
- (2013) William R. Hiatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
- (2013) Ramón Estruch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Five Percent Weight Lost in the First Month of Intragastric Balloon Treatment May Be a Predictor for Long-Term Weight Maintenance
- (2013) Umit Bilge Dogan et al. OBESITY SURGERY
- Diagnosis and Management of Nonalcoholic Fatty Liver Disease and Its Hemostatic/Thrombotic and Vascular Complications
- (2013) Christopher Byrne et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
- (2013) Takumi Hirata et al. International Journal of Endocrinology
- Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
- (2013) Beth Conlon et al. Nutrients
- When to remeasure cardiovascular risk in untreated people at low and intermediate risk: observational study
- (2013) K. J. L. Bell et al. BMJ-British Medical Journal
- Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program
- (2012) M. J. Armstrong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study
- (2012) L. Gerber et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
- (2012) Helena Bjermo et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
- (2012) James L. Trevaskis et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents Metformin and its clinical use: new insights for an old drug in clinical practice
- (2012) Arrigo F.G. Cicero et al. Archives of Medical Science
- European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
- (2012) Joep Perk et al. ATHEROSCLEROSIS
- Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
- (2012) K. Bhalla et al. Cancer Prevention Research
- Improving dietary patterns in patients with nonalcoholic fatty liver disease
- (2012) Sofia Carvalhana et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Effects of Physical Exercise on Inflammatory Markers of Atherosclerosis
- (2012) A. Pinto et al. CURRENT PHARMACEUTICAL DESIGN
- GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
- (2012) Dhanwantee Mundil et al. Diabetes & Vascular Disease Research
- Liver Fat Is Reduced by an Isoenergetic MUFA Diet in a Controlled Randomized Study in Type 2 Diabetic Patients
- (2012) L. Bozzetto et al. DIABETES CARE
- Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
- (2012) A. Neumann et al. DIABETOLOGIA
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
- (2012) G. Musso et al. DIABETOLOGIA
- If steatosis is the atherosclerosis of the liver, are statins the “aspirin” for steatosis?
- (2012) Amedeo Lonardo et al. DIGESTIVE AND LIVER DISEASE
- Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property
- (2012) Hideyuki Hyogo et al. DIGESTIVE AND LIVER DISEASE
- Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial
- (2012) Maartje E. Visser et al. EUROPEAN HEART JOURNAL
- Statins and primary liver cancer
- (2012) Danitza Pradelli et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study
- (2012) Yin-Mei Lee et al. GASTROINTESTINAL ENDOSCOPY
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- Bariatric surgery and cardiovascular outcomes: a systematic review
- (2012) Amanda R Vest et al. HEART
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Liver and diabetes. A vicious circle
- (2012) Paola Loria et al. HEPATOLOGY RESEARCH
- Bariatric Surgery and Long-term Cardiovascular Events
- (2012) Lars Sjöström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis
- (2012) Yosui Tamaki et al. JOURNAL OF GASTROENTEROLOGY
- Potential for statins in the chemoprevention and management of hepatocellular carcinoma
- (2012) Amedeo Lonardo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2012) Shelley E. Keating et al. JOURNAL OF HEPATOLOGY
- The Framingham risk score and heart disease in nonalcoholic fatty liver disease
- (2012) Sombat Treeprasertsuk et al. LIVER INTERNATIONAL
- Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD
- (2012) Stefano Ballestri et al. LIVER INTERNATIONAL
- Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects
- (2012) Lena M.S. Carlsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- 500 Intragastric Balloons: What Happens 5 Years Thereafter?
- (2012) Katerina Kotzampassi et al. OBESITY SURGERY
- Multi-Centre European Experience with Intragastric Balloon in Overweight Populations: 13 Years of Experience
- (2012) Alfredo Genco et al. OBESITY SURGERY
- Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
- (2012) Matthias Kern et al. PLoS One
- Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
- (2012) Daniel J. Cuthbertson et al. PLoS One
- Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis
- (2012) Hui Zhang et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
- (2012) Takamasa Ohki et al. TheScientificWorldJOURNAL
- Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis
- (2011) E. Boettcher et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver Disease
- (2011) Kristin D Kistler et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?
- (2011) Vasilios G. Athyros et al. ANNALS OF MEDICINE
- Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease
- (2011) Silvia Sookoian et al. ATHEROSCLEROSIS
- ESC/EAS Guidelines for the management of dyslipidaemias
- (2011) Alberico L. Catapano et al. ATHEROSCLEROSIS
- Fish oil — How does it reduce plasma triglycerides?
- (2011) Gregory C. Shearer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis
- (2011) Ping Wang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis
- (2011) Roberto Fogari et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Polymorphism in the Farnesyl Diphosphate Farnesyl Transferase 1 Gene and Nonalcoholic Fatty Liver Disease Severity
- (2011) Stefano Ballestri et al. GASTROENTEROLOGY
- Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
- (2011) Derrick M. Van Rooyen et al. GASTROENTEROLOGY
- Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
- (2011) K. Hallsworth et al. GUT
- Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus
- (2011) Tomoyuki Iwasaki et al. HEPATO-GASTROENTEROLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period
- (2011) Ayaka Hamabe et al. JOURNAL OF GASTROENTEROLOGY
- Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2011) Helen M. Parker et al. JOURNAL OF HEPATOLOGY
- Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
- (2011) Christian Thoma et al. JOURNAL OF HEPATOLOGY
- Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial
- (2011) Elena Sofer et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Combined Exenatide and Pioglitazone Therapy on Hepatic Fat Content in Type 2 Diabetes
- (2011) Padma Sathyanarayana et al. Obesity
- The renin-angiotensin system: a link between obesity, inflammation and insulin resistance
- (2011) N. S. Kalupahana et al. Obesity Reviews
- Intragastric Balloon in Association with Lifestyle and/or Pharmacotherapy in the Long-Term Management of Obesity
- (2011) Maria Grazia Farina et al. OBESITY SURGERY
- GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy
- (2011) Shvetank Sharma et al. PLoS One
- Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient – death of a dogma from analysis of therapeutic studies?
- (2011) Amedeo Lonardo et al. Expert Review of Gastroenterology & Hepatology
- Alcohol consumption appears to protect against non-alcoholic fatty liver disease
- (2010) A. Moriya et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series
- (2010) Patrick R Kenny et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
- (2010) Giovanni Musso et al. ANNALS OF MEDICINE
- n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations
- (2010) Sébastien Czernichow et al. BRITISH JOURNAL OF NUTRITION
- 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
- (2010) et al. CIRCULATION
- Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
- (2010) D. C. Chan et al. DIABETES CARE
- Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease
- (2010) P. Loria et al. DIGESTIVE AND LIVER DISEASE
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- Fitness versus fatness: Moving beyond weight loss in nonalcoholic fatty liver disease
- (2010) Nathan A. Johnson et al. HEPATOLOGY
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
- (2010) Hyohun Park et al. JOURNAL OF GASTROENTEROLOGY
- Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
- (2010) Claudia O. Zein et al. JOURNAL OF HEPATOLOGY
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Statins in the Treatment of Dyslipidemia in the Presence of Elevated Liver Aminotransferase Levels: A Therapeutic Dilemma
- (2010) Rossana M. Calderon et al. MAYO CLINIC PROCEEDINGS
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
- (2010) E. J. Mills et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Omega-3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review
- (2009) Paul E. Marik et al. CLINICAL CARDIOLOGY
- Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
- (2009) Cecilia Söderberg et al. HEPATOLOGY
- Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
- (2009) Andrea J. Cussons et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue
- (2009) Hiroshi Kudo et al. LIVER INTERNATIONAL
- Endocrine and liver interaction: the role of endocrine pathways in NASH
- (2009) Paola Loria et al. Nature Reviews Gastroenterology & Hepatology
- Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
- (2009) Eugen Florin Georgescu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
- (2008) Rajasekhara R. Mummadi et al. Clinical Gastroenterology and Hepatology
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
- (2008) Nila Rafiq et al. Clinical Gastroenterology and Hepatology
- Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis
- (2008) Paola Loria et al. CLINICAL SCIENCE
- Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
- (2008) David C. Klonoff et al. CURRENT MEDICAL RESEARCH AND OPINION
- Exenatide: clinical aspects of the first incretin-mimetic for the treatment of type 2 diabetes mellitus
- (2008) Estela Wajcberg et al. EXPERT OPINION ON PHARMACOTHERAPY
- Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease
- (2008) Winston Dunn et al. HEPATOLOGY
- Statins in liver disease: A molehill, an iceberg, or neither?
- (2008) Curtis K. Argo et al. HEPATOLOGY
- Safety and Effectiveness of the Intragastric Balloon for Obesity. A Meta-Analysis
- (2008) Iñaki Imaz et al. OBESITY SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now